Anticoagulant Medicines Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Medicines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Injectable Anticoagulant Medicines
1.2.3 Oral Anticoagulant Medicines
1.3 Market by Application
1.3.1 Global Anticoagulant Medicines Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Medicines Market Perspective (2017-2028)
2.2 Anticoagulant Medicines Growth Trends by Region
2.2.1 Anticoagulant Medicines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anticoagulant Medicines Historic Market Size by Region (2017-2022)
2.2.3 Anticoagulant Medicines Forecasted Market Size by Region (2023-2028)
2.3 Anticoagulant Medicines Market Dynamics
2.3.1 Anticoagulant Medicines Industry Trends
2.3.2 Anticoagulant Medicines Market Drivers
2.3.3 Anticoagulant Medicines Market Challenges
2.3.4 Anticoagulant Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Medicines Players by Revenue
3.1.1 Global Top Anticoagulant Medicines Players by Revenue (2017-2022)
3.1.2 Global Anticoagulant Medicines Revenue Market Share by Players (2017-2022)
3.2 Global Anticoagulant Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulant Medicines Revenue
3.4 Global Anticoagulant Medicines Market Concentration Ratio
3.4.1 Global Anticoagulant Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Medicines Revenue in 2021
3.5 Anticoagulant Medicines Key Players Head office and Area Served
3.6 Key Players Anticoagulant Medicines Product Solution and Service
3.7 Date of Enter into Anticoagulant Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulant Medicines Breakdown Data by Type
4.1 Global Anticoagulant Medicines Historic Market Size by Type (2017-2022)
4.2 Global Anticoagulant Medicines Forecasted Market Size by Type (2023-2028)
5 Anticoagulant Medicines Breakdown Data by Application
5.1 Global Anticoagulant Medicines Historic Market Size by Application (2017-2022)
5.2 Global Anticoagulant Medicines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anticoagulant Medicines Market Size (2017-2028)
6.2 North America Anticoagulant Medicines Market Size by Country (2017-2022)
6.3 North America Anticoagulant Medicines Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Anticoagulant Medicines Market Size (2017-2028)
7.2 Europe Anticoagulant Medicines Market Size by Country (2017-2022)
7.3 Europe Anticoagulant Medicines Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Medicines Market Size (2017-2028)
8.2 Asia-Pacific Anticoagulant Medicines Market Size by Country (2017-2022)
8.3 Asia-Pacific Anticoagulant Medicines Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Anticoagulant Medicines Market Size (2017-2028)
9.2 Latin America Anticoagulant Medicines Market Size by Country (2017-2022)
9.3 Latin America Anticoagulant Medicines Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Medicines Market Size (2017-2028)
10.2 Middle East & Africa Anticoagulant Medicines Market Size by Country (2017-2022)
10.3 Middle East & Africa Anticoagulant Medicines Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anticoagulant Medicines Introduction
11.1.4 Abbott Laboratories Revenue in Anticoagulant Medicines Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Aspen
11.2.1 Aspen Company Detail
11.2.2 Aspen Business Overview
11.2.3 Aspen Anticoagulant Medicines Introduction
11.2.4 Aspen Revenue in Anticoagulant Medicines Business (2017-2022)
11.2.5 Aspen Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anticoagulant Medicines Introduction
11.3.4 AstraZeneca Revenue in Anticoagulant Medicines Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Anticoagulant Medicines Introduction
11.4.4 Bayer Revenue in Anticoagulant Medicines Business (2017-2022)
11.4.5 Bayer Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Anticoagulant Medicines Introduction
11.5.4 Boehringer Ingelheim Revenue in Anticoagulant Medicines Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Anticoagulant Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Anticoagulant Medicines Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Detail
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Anticoagulant Medicines Introduction
11.7.4 Daiichi Sankyo Revenue in Anticoagulant Medicines Business (2017-2022)
11.7.5 Daiichi Sankyo Recent Development
11.8 Genentech (Roche)
11.8.1 Genentech (Roche) Company Detail
11.8.2 Genentech (Roche) Business Overview
11.8.3 Genentech (Roche) Anticoagulant Medicines Introduction
11.8.4 Genentech (Roche) Revenue in Anticoagulant Medicines Business (2017-2022)
11.8.5 Genentech (Roche) Recent Development
11.9 Johnson & Johnson.
11.9.1 Johnson & Johnson. Company Detail
11.9.2 Johnson & Johnson. Business Overview
11.9.3 Johnson & Johnson. Anticoagulant Medicines Introduction
11.9.4 Johnson & Johnson. Revenue in Anticoagulant Medicines Business (2017-2022)
11.9.5 Johnson & Johnson. Recent Development
11.10 Lilly
11.10.1 Lilly Company Detail
11.10.2 Lilly Business Overview
11.10.3 Lilly Anticoagulant Medicines Introduction
11.10.4 Lilly Revenue in Anticoagulant Medicines Business (2017-2022)
11.10.5 Lilly Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Anticoagulant Medicines Introduction
11.11.4 Merck Revenue in Anticoagulant Medicines Business (2017-2022)
11.11.5 Merck Recent Development
11.12 Otsuka
11.12.1 Otsuka Company Detail
11.12.2 Otsuka Business Overview
11.12.3 Otsuka Anticoagulant Medicines Introduction
11.12.4 Otsuka Revenue in Anticoagulant Medicines Business (2017-2022)
11.12.5 Otsuka Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Detail
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Anticoagulant Medicines Introduction
11.13.4 Pfizer Revenue in Anticoagulant Medicines Business (2017-2022)
11.13.5 Pfizer Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Anticoagulant Medicines Introduction
11.14.4 Sanofi Revenue in Anticoagulant Medicines Business (2017-2022)
11.14.5 Sanofi Recent Development
11.15 The Medicines Company
11.15.1 The Medicines Company Company Detail
11.15.2 The Medicines Company Business Overview
11.15.3 The Medicines Company Anticoagulant Medicines Introduction
11.15.4 The Medicines Company Revenue in Anticoagulant Medicines Business (2017-2022)
11.15.5 The Medicines Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anticoagulant Medicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Injectable Anticoagulant Medicines
Table 3. Key Players of Oral Anticoagulant Medicines
Table 4. Global Anticoagulant Medicines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Anticoagulant Medicines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anticoagulant Medicines Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Anticoagulant Medicines Market Share by Region (2017-2022)
Table 8. Global Anticoagulant Medicines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Anticoagulant Medicines Market Share by Region (2023-2028)
Table 10. Anticoagulant Medicines Market Trends
Table 11. Anticoagulant Medicines Market Drivers
Table 12. Anticoagulant Medicines Market Challenges
Table 13. Anticoagulant Medicines Market Restraints
Table 14. Global Anticoagulant Medicines Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Anticoagulant Medicines Market Share by Players (2017-2022)
Table 16. Global Top Anticoagulant Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Medicines as of 2021)
Table 17. Ranking of Global Top Anticoagulant Medicines Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Anticoagulant Medicines Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anticoagulant Medicines Product Solution and Service
Table 21. Date of Enter into Anticoagulant Medicines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anticoagulant Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Anticoagulant Medicines Revenue Market Share by Type (2017-2022)
Table 25. Global Anticoagulant Medicines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Anticoagulant Medicines Revenue Market Share by Type (2023-2028)
Table 27. Global Anticoagulant Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Anticoagulant Medicines Revenue Market Share by Application (2017-2022)
Table 29. Global Anticoagulant Medicines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Anticoagulant Medicines Revenue Market Share by Application (2023-2028)
Table 31. North America Anticoagulant Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Anticoagulant Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Anticoagulant Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Anticoagulant Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Anticoagulant Medicines Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Anticoagulant Medicines Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Anticoagulant Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Anticoagulant Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Anticoagulant Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Anticoagulant Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 41. Abbott Laboratories Company Detail
Table 42. Abbott Laboratories Business Overview
Table 43. Abbott Laboratories Anticoagulant Medicines Product
Table 44. Abbott Laboratories Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 45. Abbott Laboratories Recent Development
Table 46. Aspen Company Detail
Table 47. Aspen Business Overview
Table 48. Aspen Anticoagulant Medicines Product
Table 49. Aspen Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 50. Aspen Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Anticoagulant Medicines Product
Table 54. AstraZeneca Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Bayer Company Detail
Table 57. Bayer Business Overview
Table 58. Bayer Anticoagulant Medicines Product
Table 59. Bayer Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Boehringer Ingelheim Company Detail
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Anticoagulant Medicines Product
Table 64. Boehringer Ingelheim Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Bristol-Myers Squibb Company Detail
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Anticoagulant Medicines Product
Table 69. Bristol-Myers Squibb Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Daiichi Sankyo Company Detail
Table 72. Daiichi Sankyo Business Overview
Table 73. Daiichi Sankyo Anticoagulant Medicines Product
Table 74. Daiichi Sankyo Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 75. Daiichi Sankyo Recent Development
Table 76. Genentech (Roche) Company Detail
Table 77. Genentech (Roche) Business Overview
Table 78. Genentech (Roche) Anticoagulant Medicines Product
Table 79. Genentech (Roche) Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 80. Genentech (Roche) Recent Development
Table 81. Johnson & Johnson. Company Detail
Table 82. Johnson & Johnson. Business Overview
Table 83. Johnson & Johnson. Anticoagulant Medicines Product
Table 84. Johnson & Johnson. Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 85. Johnson & Johnson. Recent Development
Table 86. Lilly Company Detail
Table 87. Lilly Business Overview
Table 88. Lilly Anticoagulant Medicines Product
Table 89. Lilly Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 90. Lilly Recent Development
Table 91. Merck Company Detail
Table 92. Merck Business Overview
Table 93. Merck Anticoagulant MedicinesProduct
Table 94. Merck Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Otsuka Company Detail
Table 97. Otsuka Business Overview
Table 98. Otsuka Anticoagulant MedicinesProduct
Table 99. Otsuka Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 100. Otsuka Recent Development
Table 101. Pfizer Company Detail
Table 102. Pfizer Business Overview
Table 103. Pfizer Anticoagulant MedicinesProduct
Table 104. Pfizer Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Sanofi Company Detail
Table 107. Sanofi Business Overview
Table 108. Sanofi Anticoagulant MedicinesProduct
Table 109. Sanofi Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 110. Sanofi Recent Development
Table 111. The Medicines Company Company Detail
Table 112. The Medicines Company Business Overview
Table 113. The Medicines Company Anticoagulant MedicinesProduct
Table 114. The Medicines Company Revenue in Anticoagulant Medicines Business (2017-2022) & (US$ Million)
Table 115. The Medicines Company Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulant Medicines Market Share by Type: 2021 VS 2028
Figure 2. Injectable Anticoagulant Medicines Features
Figure 3. Oral Anticoagulant Medicines Features
Figure 4. Global Anticoagulant Medicines Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Others Case Studies
Figure 9. Anticoagulant Medicines Report Years Considered
Figure 10. Global Anticoagulant Medicines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Anticoagulant Medicines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Anticoagulant Medicines Market Share by Region: 2021 VS 2028
Figure 13. Global Anticoagulant Medicines Market Share by Players in 2021
Figure 14. Global Top Anticoagulant Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Medicines as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Anticoagulant Medicines Revenue in 2021
Figure 16. North America Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Anticoagulant Medicines Market Share by Country (2017-2028)
Figure 18. United States Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Anticoagulant Medicines Market Share by Country (2017-2028)
Figure 22. Germany Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Anticoagulant Medicines Market Share by Region (2017-2028)
Figure 30. China Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Anticoagulant Medicines Market Share by Country (2017-2028)
Figure 38. Mexico Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Anticoagulant Medicines Market Share by Country (2017-2028)
Figure 42. Turkey Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Anticoagulant Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Abbott Laboratories Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 45. Aspen Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 46. AstraZeneca Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 47. Bayer Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 50. Daiichi Sankyo Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 51. Genentech (Roche) Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 52. Johnson & Johnson. Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 53. Lilly Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 54. Merck Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 55. Otsuka Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 58. The Medicines Company Revenue Growth Rate in Anticoagulant Medicines Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Industry Market Size
